The pharmaceutical manufacturing industry is under pressure more than ever before to improve their processes and cost effectiveness. They require equipment that can help shorten validation time, comply with standards and guidelines, and reduce the total cost of ownership. 

“Our new STERIS washing solution offers several innovative features that are designed to provide an even higher level of assurance of consistent cleaning results,” comments Olivier Van Houtte, Product Manager for STERIS Life Sciences. “For example, the rotation of the chamber’s spray arms can be monitored to ensure that the spray coverage of all the items in the load is constant and complete.” 

The new Reliance 980PG system complies with the ASME BPE (Bio Processing Equipment) standard, which relates to the requirements applicable to system design for bioprocessing, pharmaceutical and personal care product industries. The “Electronic Data Security” Options allow users to configure a comprehensive, yet cost effective system to manage vital electronic data and comply with FDA 21 CFR Part 11 and European Annex 11 requirements. 

 

Customers can contact their local STERIS Capital Equipment Solutions Representatives for more information or to order.

For more information about this and other STERIS Laboratory technologies, please visit http://www.sterislifesciences.com and select the “Research and Laboratory” market application. 

STERIS's mission is to help our Customers create a healthier and safer world by providing innovative healthcare and life science product and service solutions around the globe. For more information, visit www.steris.com. 

####

This news release may contain statements concerning certain expectations, forecasts, estimates, product performance or other forward-looking information affecting or relating to the Company or its products that are intended to qualify for the protections afforded "forward- looking statements" under the Private Securities Litigation Reform Act of 1995 and other laws and regulations. Forward-looking statements speak only as to the date of this report, and may be identified by the use of forward-looking terms such as "may," "will," "expects," "believes," "anticipates," "plans," “new,” “advanced,” and “best available,” or the negative of such terms or other variations on such terms or comparable terminology. Many important factors could cause actual results to differ materially from those in this news release including, without limitation, disruption of production or supplies, changes in product use, pending or future claims, technology advances, and changes in government regulations or the application or interpretation thereof. No assurances can be provided as to any product performance or product safety unless all labeling, instructions for use, MSDS and other product literature are strictly followed. Unless legally required, the Company does not undertake to update or revise any forward-looking statements even if events make clear that any projected results, express or implied, will not be realized. Other potential risks and uncertainties that could cause actual results to differ materially from those in this news release include, without limitation, (a) the possibility that market demand will not develop for new technologies, products or application; (b) the possibility that application of or compliance with laws, court rulings, regulations, certifications or other requirements or standards may delay or prevent product introductions, affect the production and marketing of existing products, or otherwise affect product performance; or (c)uses not consistent with product instructions. Product descriptions and performances herein are for illustration only and do not modify labeling, warranties or other technical literature.